Home Special Topics Technology Offerings Content

molecular marker for minimally invasive diagnostics of either cerebral tumours or inflammable diseases

next article

14.10.2008

The work group of Prof. Dr. Eckart Meese at Saarland University identified special features of tumour cells that could constitute a basis for an improved special diagnostic investigation. Tumour antigens were identified which trigger an immune reaction exclusively in patients with glioms or meningeoms. Based on this success re-search was extended on the fields of MS and COPD. Compared with common procedures, the minimally invasive diagnosis, based on blood analysis, is a very cost-efficient method. Furthermore, this procedure means less inconveniences for the patient (complete blood count only).

Further Information: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340

Contact
Dipl. Chem. Dagmar Vössing, Dipl.-Kfm. Axel Koch MBA, Dipl. Ing. Gerd Schneider

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=0343&lang=en
www.technologieallianz.de

next article